Free Trial

Absci (ABSI) Competitors

Absci logo
$2.76 +0.07 (+2.42%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$2.77 +0.02 (+0.69%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ABSI vs. VVX, UPBD, OLO, CRTO, ASTH, FLYW, STGW, RDWR, ETWO, and EVH

Should you be buying Absci stock or one of its competitors? The main competitors of Absci include V2X (VVX), Upbound Group (UPBD), OLO (OLO), Criteo (CRTO), Astrana Health (ASTH), Flywire (FLYW), Stagwell (STGW), Radware (RDWR), E2open Parent (ETWO), and Evolent Health (EVH). These companies are all part of the "business services" industry.

Absci vs. Its Competitors

V2X (NYSE:VVX) and Absci (NASDAQ:ABSI) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

V2X presently has a consensus target price of $62.80, indicating a potential upside of 27.22%. Absci has a consensus target price of $8.40, indicating a potential upside of 204.90%. Given Absci's stronger consensus rating and higher probable upside, analysts clearly believe Absci is more favorable than V2X.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
V2X
2 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.64
Absci
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

95.2% of V2X shares are owned by institutional investors. Comparatively, 52.1% of Absci shares are owned by institutional investors. 1.1% of V2X shares are owned by insiders. Comparatively, 10.5% of Absci shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, V2X and V2X both had 4 articles in the media. Absci's average media sentiment score of 0.60 beat V2X's score of 0.31 indicating that Absci is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
V2X
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Absci
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

V2X has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Comparatively, Absci has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500.

V2X has higher revenue and earnings than Absci. Absci is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
V2X$4.32B0.36$34.68M$1.2938.27
Absci$4.53M77.58-$103.11M-$0.92-2.99

V2X has a net margin of 0.96% compared to Absci's net margin of -2,232.13%. V2X's return on equity of 13.97% beat Absci's return on equity.

Company Net Margins Return on Equity Return on Assets
V2X0.96% 13.97% 4.49%
Absci -2,232.13%-53.69%-45.89%

Summary

V2X beats Absci on 10 of the 16 factors compared between the two stocks.

Get Absci News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABSI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABSI vs. The Competition

MetricAbsciMED IndustryMedical SectorNASDAQ Exchange
Market Cap$353.34M$2.91B$5.56B$9.04B
Dividend YieldN/A2.44%5.22%3.99%
P/E Ratio-2.9921.5627.6620.25
Price / Sales77.58283.36423.00177.43
Price / CashN/A42.7336.8958.10
Price / Book1.777.518.035.67
Net Income-$103.11M-$55.14M$3.18B$249.21M
7 Day Performance5.15%4.61%2.93%3.28%
1 Month Performance-9.08%0.90%1.72%3.95%
1 Year Performance-13.09%5.40%34.39%20.98%

Absci Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABSI
Absci
2.0806 of 5 stars
$2.76
+2.4%
$8.40
+204.9%
-13.1%$353.34M$4.53M-2.99210News Coverage
Analyst Forecast
Gap Up
VVX
V2X
3.9794 of 5 stars
$45.75
+2.2%
$63.67
+39.2%
+4.1%$1.42B$4.32B35.4716,100
UPBD
Upbound Group
4.5585 of 5 stars
$23.92
-1.2%
$34.50
+44.2%
-9.7%$1.40B$4.32B5.9911,970Positive News
OLO
OLO
1.4742 of 5 stars
$8.52
+1.9%
$9.00
+5.7%
+135.9%$1.39B$299.11M425.96710Trending News
Analyst Downgrade
Options Volume
Gap Up
CRTO
Criteo
4.1929 of 5 stars
$23.68
+0.3%
$46.70
+97.2%
-37.6%$1.37B$1.93B9.633,507News Coverage
Gap Up
ASTH
Astrana Health
3.3039 of 5 stars
$25.07
+4.5%
$53.29
+112.5%
-36.4%$1.35B$2.03B34.821,900News Coverage
Analyst Revision
FLYW
Flywire
4.3159 of 5 stars
$11.02
+1.6%
$15.00
+36.1%
-26.2%$1.32B$492.14M108.501,250
STGW
Stagwell
2.5338 of 5 stars
$4.43
-0.4%
$8.60
+94.1%
-33.4%$1.19B$2.84B9.8914,607Positive News
RDWR
Radware
2.8225 of 5 stars
$28.25
+2.8%
$27.00
-4.4%
+59.0%$1.17B$274.88M104.631,208
ETWO
E2open Parent
1.0786 of 5 stars
$3.24
+0.5%
$2.78
-14.2%
-29.0%$1.11B$607.69M-1.513,873News Coverage
Upcoming Earnings
High Trading Volume
EVH
Evolent Health
1.733 of 5 stars
$10.52
+13.7%
$17.79
+69.1%
-41.0%$1.09B$2.55B-8.554,500High Trading Volume

Related Companies and Tools


This page (NASDAQ:ABSI) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners